chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My COVID-19 infection symptoms started in the early morning on 03/01/2023. I had a severe headaches including back of my head, chills, fever, extremely tired and my lymph nodes were swollen. I had a productive cough that started from the night of 03/02/2023 through 03/03/2023. I took a COVID-19 test on 03/02/2023 which was positive. In the morning when I was going to the bathroom I felt like I was going to faint. I went to the urgent care on 03/02/2023 they just checked my blood pressure but they didn't do any other test. They prescribe me PAXLOVID for 5 days. I still have the cough as of today 03/16/2023 but better than before.
Post vaccination patient reports soreness of Left arm, light headedness, nausea, and feeling cold. Sent for observation 5:15pm  vitals: Pulse 90 BP 131/81 RESP 16. At 5:34pm Pulse 81 BP 118/89 RESP 16. Patient improved with no other symptoms., and released from facility.
After second vaccination woke up the following day with sever head aches which lasted until the next morning; Body aches lasting 2 days; Extreme tiredness, missed 2.5 days of work; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the left arm on 21Apr2021 at 11:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included RA (Rheumatoid Arthritis) and fibromyalgia. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included methotrexate (MANUFACTURER UNKNOWN), calcium folinate (LEUCOVORIN CALCIUM), fish oil (OMEGA 3) and glucose (MANUFACTURER UNKNOWN); all for unknown indications from unknown date. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 31Mar2021 at 13:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 05:30 after the second vaccination the patient woke up the following day with severe headaches which lasted until the next morning, body aches lasting 2 days and extreme tiredness. The patient missed 2.5 days of work. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovered on 23Apr2021. The clinical outcome of the event body aches was recovered on 24Apr2021, while that of the event tiredness was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
received a dose of PEDIARIX and IPOL; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 6-year-old female patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis and POLIOMYELITIS VACCINE INACTIVATED (IPOL VACCINE) for prophylaxis.   On 26th January 2023, the patient received Pediarix, Pediarix Pre-Filled Syringe Device and IPOL VACCINE. On 26th January 2023, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced overdose. On an unknown date, the outcome of the overdose was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-JAN-2023 Reporter's Comment: The reporter was the medical assistant who stated that a patient received a dose of Pediarix an Ipol vaccine at the time of reporting. Both vaccines contained inactive poliovirus. The reporter consented to follow up. Additional Supportive Information: The reporter was the medical assistant who stated that a patient received a dose of Pediarix and Ipol vaccine at the time of reporting, which led to overdose.
Not sure when it actually started, as I had fever like symptoms the day after, but ever since I have had a ringing in my ears.   With background noise or doing some kind of activity it sufficiently distracts me from it but it's quite clear in the morning and night.   Hasn't gotten better or worse.
After receiving vaccines approx 10-15min, Pt developed small urticarial rash on body. No dyspnea wheezing; complained of itching only. Pt was evaluated in the ER and given Benadryl, prednisone. Hives disappeared the following day. Telephone f/u with parent indicating pt is doing fine.
Within 30 minutes of receiving the influenza vaccine and with BENADRYL on board, developed a severe migraine HA, tightness of the jaw, hot/cold flashes, arthralgia, weakness, lightheadedness, tunnel vision, clammy skin, facial flushing.
Death; A spontaneous report was received from a reporter concerning a 56-year old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and had experienced death.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 23 Dec 2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch:  unknown) for prophylaxis of COVID-19 infection.  On 08 Jan 2021, the patient died. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not applicable.   The patient died on 08 Jan 2021. The cause of death was not provided. Plans for an autopsy were not provided.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.; Reported Cause(s) of Death: unknown cause of death
Information has been received from a pharmacist concerning an 18 year old female who on 10-NOV-2007 was vaccinated with the first dose of Gardasil. Concomitant therapy included CHEMET. The patient has been receiving CHEMET for mercury poisoning and was to complete a 2 year course of treatment. The patient had been taking CHEMET four times per day for several months without problem. On 11-NOV-2007 the patient experienced lip swelling, mouth swelling and throat swelling. The patient contacted her physician by phone and was suggested to stop the CHEMET. The patient discontinued the CHEMET and the symptoms resolved without treatment. After 3 weeks, the patient restarted taking CHEMET and the lip, mouth, and throat swelling returned the next day. The patient has discontinued CHEMET and has fully recovered. The patient will not receive further doses of Gardasil. No further information is available. Additional information is not expected.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On 30-OCT-2015, the patient was administered one dose of ZOSTAVAX subcutaneously, lot# L021612 exp. 10-SEP-2016 (dose was not reported) as indicated and inadvertently administered one dose of (Oka/Merck) VARIVAX intramuscularly lot # L012035 exp. 07-APR-2017 (dose was not reported) as well. There was no adverse effects reported. Additional information has been requested.
difficulty breathing, paleness, weakness, fast heart beat, dizziness, paleness, weakness, fast heart beat, nausea
Information has been received from a Physician's Assistant concerning a female patient who on 26-JUN-2007 was vaccinated IM with her third dose of Gardasil. After the third dose, the patient developed enlarged lymphnodes. The patient had no reaction to the first and second doses. Unspecified medical attention was sought. Her outcome was unknown. Additional information has been requested.
pt recvd vax 28NOv89 & 9DEC89 devel low grade fever, malaise, & nausea followed by polyarthritis on 13DEC89;
Within 24 hours of injection, fever of 101.0 for over 24 hours, headache, inability to keep awake or keep eyes open, worsened my IBS and my neuropathy to the point of screaming, my body couldn't detect temperature changes even when inside room temp went from 70 to 86 degrees. Three times I fell into semi-conscious state and awoke within minutes not knowing where I was at or what was happening to me. Symptoms went away around 60 hours after injection.
Cough and shortness of breath 5 hours after VARIVAX vaccine, H1N1, seasonal flu which improved with BENADRYL, cough returned following day improved with BENADRYL, today much improved, no fever or viral illness per parent.
Saturday 3/13 - Moderna shot @10am on L arm. Onset of sx @6pm. Fatigue, irritability, mild body aches   Sunday 3/14 - Upon waking Fatigue and severe body aches. Painful to walk, exert, lift a spoon. Required some assistance with activities of daily living. Nausea. Some improvement around 6pm.   Monday 3/15 - Upon waking Decreased fatigue, body aches resolved, nausea resolved. Soreness and fatigue in carpel tunnel area, feeling as though I had held a heavy phone for too long. Adjusted by keeping off phone during the day. Hand/wrist pain increased in the evening. Noted wrist and hand swelling @8pm. After applying ice around 10:30pm pain became suddenly severe with movement. Suspected ice was somehow a mistake and applied heat. Pain became excruciating. Took tylenol XS to sleep.   Tuesday 3/16 - Upon waking Moderate swelling and complete loss of mobility in both hands and wrists. Shooting pain that knocked the breath out of me. Unable to complete any activities of daily living independently (bathing, toileting, eating). Wore carpel tunnel braces all day. Some improvement in range of motion in the evening, able to open and rest hands semi-flat on an angled surface. R hand demonstrating faster improvement than L. Noted mild red bumps present on both wrists (more on L) and mild-moderate shooting pain from L thumb toward inner elbow, more severe in area closer to elbow. Upon rubbing the area close to elbow noted soreness and bumps under skin when applying mild pressure that aren't visible to the eye.   Wednesday 3/17 - Upon waking Red bumps resolved. Some improvement in all areas. L hand improvements mildly lagging behind the R. Able to complete activities of daily living with supportive assistance. Increased range of motion and moderate pain. More improvement @5pm. Regained 90% range of motion, shooting pains were mild-moderate.   Thursday 3/18 - Upon waking I have full range of motion. Mild-moderate pain with certain angled movements and levels of exertion. PCP telehealth appt @9am. Diagnosis: adverse reaction to moderna. Suspicion that there may be some connection with the complex migraine (though there was no numbness or tingling present) and to update my neurologist (you!). Recommendation was to report it and monitor sx. If sx not completely resolved in one week referral to othopedic.
Chills; Fever; Feeling bad; Inappropriate Reconstitution Technique; Inappropriate dose of vaccine administered; This case was reported by a nurse via call center representative and described the occurrence of chills in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles and nerve pain. Previously administered products included Shingrix (1st dose received on 12th August 2019, refer case US2019201169).   On 4th November 2019, the patient received the 2nd dose of Shingrix. On 4th November 2019, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On 5th November 2019, the patient experienced chills, fever and feeling bad. On an unknown date, the outcome of the chills, fever and feeling bad were not recovered/not resolved and the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the chills, fever and feeling bad to be related to Shingrix.  Additional case details were reported as follows: The reporter was patient's wife. The patient initially received only the adjuvant part of the vaccine, it was not reconstituted before, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.  The patient then received a full dose of the vaccine. On day of reporting, the patient wake up with chills, fever and feeling bad. The reporter consent to follow up. This case had been linked to the case US2019201169, reported for same patient.
Patient's atrial fibrillation worsened after receiving second shot, requiring 4 cardioversions
Lightheadedness, numbness (arms and legs), dizziness, Shakiness. Gave patient water and some food. Said she felt better, but the symptoms came back. Treated with hydroxyzine in the hospital.
began to have intense itching aprox 15mins p/vax then arm began to swell & became erythematous from shoulder to elbow w/in approx 4 hrs; did not go to PMD for tx
Patient with history of diabetes type II, CKD, and Afib with RVR. She was brought to the ED by EMS on 2/16/23 for shortness of breath. She has been feeling ill for the past week and a half, and reports symptoms of chest pain, shortness of breath, cough, chills, nausea, and diarrhea. In the ED, she was found to be in atrial fibrillation with RVR and had a positive COVID-19 PCR test. She was admitted 2/16/23 - 2/22/23 for atrial fibrillation with RVR in the setting of COVID-19 infection. She was treated with IV dexamethasone during admission. Per the chart, the patient has received the primary COVID vaccine series and two booster doses.
Fever 102.5 degrees, vomiting, lethargy, runny nose, cough, aches. Two days so far
I started with fatigue and runny nose. That evening, I developed chills. After that, and for the next couple of days I continued to have a runny nose. I never felt too bad.
L thigh redness, warmth and edematous area of about 1 x 1.5 inch. Started on 3/18/ 2010 in the evening according to mother. Child seen at the clinic today @ ice, TYLENOL q 4 hours as order by PCP.
Extreme vertigo episodes (began with a few up to 60 episodes per day lasting 5 to 25 seconds) Extreme arm and leg aches Extreme fatigue Frontal lobe headache
8 days after receiving my COVID 19 immunization, my left arm became red , hot, and itchy. I developed an orange sized welt on my arm (in the deltoid area where the vaccine was administered). The swelling has gone down, but there is still redness without warmth and some itchiness intermittently.  I work in a hospital as an RN and showed the welt to one of the doctors I work with, who said he?s heard that many people have had this type of reaction. I am taking Claritin daily but have taken no other medications, nor have I sought medical care.
Chills; Fatigue; Body aches; Headache; Nausea; Vomiting; Off label use; Booster dose administered; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30155BA) via an unspecified route of administration in the left arm on 01Oct2021 at 11:15 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. The medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Jan2021 at 08:00 (at the age of 73-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 08:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. On 02Oct2021 at 08:30, the patient experienced chills, fatigue, body aches, headache, nausea and vomiting. On an unknown date in 2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events chills, fatigue, body aches, headache, nausea and vomiting were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Mother called health department 10/30/02 to inform public health nurse  was treated in ER 9/12/02 approximately 4 hours after vaccines administered.  Shortness of breath and generalized hives.  Right arm was swollen from elbow to shoulder and area where vaccine given was blanched with surrounding erythema.  Upper arm remained swollen for 10 days.  Completely resoved after 10 days.  DTaP was the opnly vaccine administered in the right deltoid area.
turned her ankle, can hardly move it/hurting her ankle; This is a spontaneous report from a contactable consumer or other non hcp.     An 81-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 25Jan2021 (Batch/Lot Number: EL9263) as DOSE 1 SINGLE for covid 19 immunization. Medical history included surgery from Dec2018. She states she has had many eye surgeries but the last eye surgery was in Dec2018. The patient's concomitant medications were not reported. It was reported that, the patient experienced turned her ankle, can hardly move it/hurting her ankle on 08Feb2021 with outcome of unknown.  Follow-up attempts are completed. No further information is expected.
Once vaccine was administered patient started having chills, numbness in hands, weak, and nausea.  Our BP machine could not register BP, once EMS arrived they took BP of 90/64.  We had patient sit for 45 minutes until he felt better and BP can up.
Vaccine injection site high on shoulder.  Severe arm pain, injection site bruising and swelling. Nerve pain, fever, muscle soreness, headache, nausea.
mild headache; Sore arm 11 hours post-vaccine; more tired than normal that evening; This is a spontaneous report from a contactable consumer. A 45-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot Number: EN 6199) via an unspecified route of administration administered in right arm on 09Mar2021 09:45 (at 45 years old) as single dose for COVID-19 immunization. There were no other vaccinations within 4 weeks prior to the first dose of BNT162B2. Medical history included high blood pressure, acid reflux, fatty liver, and overweight; all from unspecified date and unknown if ongoing. Concomitant medications included unspecified blood pressure and acid reflux medicines. The patient did not have COVID prior vaccination and no COVID tests done post vaccination. The patient experienced sore arm 11 hours post-vaccine and more tired than normal that evening on 09Mar2021. The patient also experienced mild headache the next morning on 10Mar2021. All were non-serious. No treatment was given due to the events. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Diarrhea for 10 days. No other notable signs. No fever. No fussiness.  Appetite/intake normal.
Mild Seizure including auditory hallucination. Was a little scary but came out of it and had family member monitor me for possible emergency care & transport to hospital. Events did not reoccur so did not seek medical care. Took it easy today and rested. So far still OK, just nervous about getting second dose.
Currently in hospital with myocarditis; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (Currently in hospital with myocarditis) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (Currently in hospital with myocarditis) (seriousness criteria hospitalization and medically significant). At the time of the report, MYOCARDITIS (Currently in hospital with myocarditis) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided. As per social media, patient won't live past 30. Treatment information was not reported.  Company comment: This is a spontaneous case concerning a 25-years-old male patient with no reported medical history, who experienced the expected serious (hospitalization and medically significant) adverse event of special interests of myocarditis. The event occurred on unknown day after the unknown dose of mRNA-1273 vaccine. No information disclosed about diagnostic tests performed or treatments received. At the time of the report, event was not resolved. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Events seriousness assessed as reported.     Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2022: Live Follow-up received include : Patient age added. On 04-Nov-2022: Live follow up received and updated patient information and details were added, reporter information also added.; Sender's Comments: This is a spontaneous case concerning a 25-years-old male patient with no reported medical history, who experienced the expected serious (hospitalization and medically significant) adverse event of special interests of myocarditis. The event occurred on unknown day after the unknown dose of mRNA-1273 vaccine. No information disclosed about diagnostic tests performed or treatments received. At the time of the report, event was not resolved. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Events seriousness assessed as reported.
PRETTY  ACHY BACK; This spontaneous report received from a patient concerned a 77 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) dose was not reported, administered on 13-MAR-2021 22:00 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced pretty achy back. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pretty achy back on 14-MAR-2021. This report was non-serious.